Have a personal or library account? Click to login
Evaluation of the Early Results of Percutaneous Ethanol Ablation in Patients with Primary Hyperparathyroidism Cover

Evaluation of the Early Results of Percutaneous Ethanol Ablation in Patients with Primary Hyperparathyroidism

Acta Medica Bulgarica
Volume 49 (2022): Issue 1 (April 2022)
By: I. Yankova,  A. Shinkov and  R. Kovatcheva  
Open Access
|Apr 2022

Authors

I. Yankova

inna.yankova1@gmail.com

Department of Thyroid and Metabolic Bone Diseases, University Hospital of Endocrinology “Acad. Ivan Penchev”, Department of Endocrinology, Medical University – Sofia, Bulgaria

A. Shinkov

Department of Thyroid and Metabolic Bone Diseases, University Hospital of Endocrinology “Acad. Ivan Penchev”, Department of Endocrinology, Medical University – Sofia, Bulgaria

R. Kovatcheva

Department of Thyroid and Metabolic Bone Diseases, University Hospital of Endocrinology “Acad. Ivan Penchev”, Department of Endocrinology, Medical University – Sofia, Bulgaria
DOI: https://doi.org/10.2478/amb-2022-0001 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Journal RSS Feed
Language: English
Page range: 5 - 11
Submitted on: Jan 1, 2022
Accepted on: Jan 6, 2022
Published on: Apr 22, 2022
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
percutaneous ethanol ablation,
primary hyperparathyroidism,
parathyroid adenoma,
hypercalcemia
Related subjects:
Medicine,
Basic medical science,
Immunology,
Clinical medicine,
Clinical medicine, other

© 2022 I. Yankova, A. Shinkov, R. Kovatcheva, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 49 (2022): Issue 1 (April 2022)Next article